Abeona Therapeutics Inc vs Shopify Inc. — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Shopify Inc. trades at $151.37 (market cap $196.35B). The key difference: Shopify Inc. is far larger — about 466.2× Abeona Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Shopify Inc. nearer its low. Which is the better fit depends on your goals.
| ABEO | SHOP | |
|---|---|---|
Market Cap | $421.19M | $196.35B |
Sector | Health | Technology |
52-Week High | $7.45 | $179.01 |
52-Week Low | $4.17 | $95.40 |
Enterprise Value | $276.10M | $191.59B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Shopify (SHOP) trades at $155.18, up 2.38% today, following strong Q2 2026 earnings beats. The stock exhibits a bullish technical trend with support at $151 and resistance at $158. Revenue growth remains robust, with 2025 revenue reaching $11.56B, though valuation multiples like a P/E of 103.11 are elevated. Positive analyst sentiment is driven by AI commerce integration and expanding gross merchandise volume.
Outlook is positive given earnings momentum and AI-driven growth, but high valuation and competitive e-commerce pressures pose risks. The consensus price target of $166.39 suggests modest upside, supported by 65.62% of analysts rating it Buy. Investors should weigh growth prospects against premium pricing.
Trailing returns across standard periods
Latest headlines on both assets
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →